It was FDA-approved in 1997 under the brand name Geref for growth hormone deficiency in children, administered exclusively as a subcutaneous injection
But, while these two compounds might sound similar in name, they couldn't be more different when it comes to the ways in which they support your health
Managing Side Effects During Dose Increases Whenever you step up to a higher concentration of tirzepatide, there is a window of 48 to 72 hours where side effects are most likely to peak
There are also no data on metabolic control, the severity of T2DM, the body mass index of the patients with obesity, or the estimation of cardiovascular risk, which implies continuing with this line of research to establish other variables of interest
The impetus is fully on you as the consumer to utilize these services if you want to get your moneys worth